Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 12 May 21 EFFECT Notice of effectiveness
- 11 May 21 424B3 Prospectus supplement
- 10 May 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 3 May 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
13 Apr 21 S-4 Registration of securities issued in business combination transactions
TPST similar filings
- 10 May 21 Registration of securities issued in business combination transactions (amended)
- 3 May 21 Registration of securities issued in business combination transactions (amended)
- 13 Apr 21 Registration of securities issued in business combination transactions
- 2 Nov 18 Registration of securities issued in business combination transactions (amended)
- 1 Nov 18 Registration of securities issued in business combination transactions (amended)
- 26 Sep 18 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 29, 2021, included in the Proxy Statement of Millendo Therapeutics, Inc. that is made a part of the Registration Statement (Form S-4) and Prospectus of Millendo Therapeutics, Inc. for the registration of its common stock.
/s/ Ernst & Young LLP |
Grand Rapids, Michigan |
April 13, 2021 |